Trisectionectomy for cholangiocarcinoma: is it worth it?

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Cholangiocarcinoma treatment often involves aggressive liver resection for improved survival.
• Extensive tumor burden may necessitate trisectionectomy, increasing risks of liver insufficiency and complications.

Purpose of the Study:

• To compare outcomes of liver resection versus trisectionectomy in cholangiocarcinoma patients.
• To evaluate the safety and efficacy of trisectionectomy for extensive cholangiocarcinoma.

Main Methods:

• Retrospective review of 62 cholangiocarcinoma patients from 2000-2010.
• Comparison of 17 trisectionectomy patients with 21 liver resection patients.
• Pathology rereview and analysis of demographics, complications, and survival.

Main Results:

• No significant differences in demographics or complications between liver resection and trisectionectomy groups.
• Pathology results showed no significant differences between the two groups.
• Median survival was comparable: 2.9 years for liver resection and 2.8 years for trisectionectomy.

Conclusions:

• Trisectionectomy is a safe procedure for cholangiocarcinoma when aiming for complete disease clearance.
• Outcomes, including survival and complications, are comparable to less extensive liver resections.
• Complete resection with negative margins remains the surgical goal for cholangiocarcinoma.